MedTrace Logo

Efficacy of MI078 Capsules in Treating Postpartum Depression

NCT06963580 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-08-26

No results posted yet for this study

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled trial. It includes three groups. Each group will enroll 24 participants. The trial aims todetermine： To evaluate the efficacy of MI078 capsules in treating postpartum depression and to explore the optimal dosing regimen for MI078 capsules.

To assess the safety of MI078 capsules in postpartum depression patients.

Conditions

Interventions

DRUG

MI078 capsule dose 1

MI078 capsule dose 1 for 3 days

DRUG

MI078 capsule dose 2

MI078 capsule dose 2 for 3 days

DRUG

placebo

placebo for 3 days

Sponsors & Collaborators

  • Nanjing Minova Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • huafang Li · Shanghai Mental Health Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-09
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06963580 on ClinicalTrials.gov